Somatostatin ameliorates lipopolysaccharide-induced tight junction damage via the ERK-MAPK pathway in Caco2 cells

European Journal of Cell Biology

Volumn 93, Issue 7, 2007, Pages 299-307

  Lei, Shan ^a   Cheng, Tianming ^a   Guo, Yandong ^a   Li, Chen ^a   Zhang, Wendi ^a   Zhi, Fachao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

ERK MAPK pathway; Lipopolysaccharide; Permeability; Somatostatin; Tight junction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCCLUDIN; PROTEIN ZO1; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 5; 1,3 BUTADIENE DERIVATIVE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRILE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; METABOLISM; PERMEABILITY; SIGNAL TRANSDUCTION;

BUTADIENES; CACO-2 CELLS; CELL SURVIVAL; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; OCCLUDIN; PERMEABILITY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TIGHT JUNCTIONS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84929045311     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2014.05.003     Document Type: Article

References (48)

1. Alessio F., Joerg D. The role of the intestinal barrier function in the pathogenesis of celiac disease. Pediatr. Adolesc. Med. 2008, 12:89-98.
2. Al-Sadi Rana M., Ma Thomas Y. IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 2007, 178:4641-4649.
3. Andrea Hartsock W., Nelson J. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 2008, 1778:660-669.
4. Arias-Diaz J., Vara E., Torres-Melero J., et al. Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: effects of pentoxifylline and somatostatin. Eur. J. Surg. 1997, 163:619-625.
5. Badway A.C., West F.M., Tente S.M., Blake A.D. Somatostatin regulates intracellular signaling in human carotid endothelial cells. Biochem. Biophys. Res. Commun. 2004, 319:1222-1227.
6. Basivireddy J., Somvanshi R., Romero I., et al. Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis. Biochem. Pharmacol. 2013, 86:497-507.
7. Basuroy S., Seth A., Elias B., et al. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem. J. 2006, 393:69-77.
8. Capaldo Christopher T., Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta 2009, 1788:864-871.
9. Chakravortty D., Kumar K.S. Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNF alpha in inducing barrier dysfunction. Microbiol. Immunol. 1999, 43:527-533.
10. Chen Yh, Lu Q., Schneeberger E.E., Goodenough D.A. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cell. Mol. Biol. Cell. 2000, 11:849-862.
11. Chin A.C., Flynn A.N., Fedwick J.P. The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctions. Can. J. Physiol. Pharmacol. 2006, 84:1043-1050.
12. Chowers Y., Cahalon L., Lahav M., et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-a- and bacteria-induced IL-8 and IL-1b secretion from intestinal epithelial cells. J. Immunol. 2000, 165:2955-2961.
13. Colucci R., Blandizzi C., Ghisu N., et al. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation. Br. J. Pharmacol. 2008, 155:198-209.
14. Costantini Todd W., Peterson Carrie Y., Kroll L., et al. Role of p38 MAPK in burn-induced intestinal barrier breakdown. J. Surg. Res. 2009, 156:64-69.
15. Courtois F., Seidman Ernest G., Delvin E., et al. Membrane peroxidation by lipopolysaccharide and iron-ascorbate adversely affects Caco-2 cell function: beneficial role of butyric acid. Am. J. Clin. Nutr. 2003, 77:744-750.
16. Forsythe R.M., Xu D.Z., Lu Q. Lipopolysaccharide-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion. Shock 2002, 17:180-184.
17. Gäbele E., Dostert K., Hofmann C., et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J. Hepatol. 2011, 55:1391-1399.
18. Gibson R.Peter, Anderson P Robert, Mariadason M.John, Wilson J.Andrew Protective role of the epithelium of the small intestine and colon. Inflamm. Bowel Dis. 1996, 2:279-302.
19. Guo S., AlSadi R., Said H.M., Ma T.Y. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 2013, 182:375-387.
20. Han X., Fink M.P., Yang R., Delude R.L. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 2004, 21:261-270.
21. Hanson A., Poudyal D., Hagemeister A., Reindl K.M., Sheridan M.A. The ERK and PI3K signaling pathways mediate inhibition of insulin-like growth factor-1 receptor mRNA expression by somatostatin. Mol. Cell Endocrinol. 2010, 315:57-62.
22. Hanson P.J., Moran A.P., Butler K. Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. Innate Immun. 2011, 17:269-282.
23. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995, 270:1203-1207.
24. Holst N., Jacobsen M.B., Haug E. Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells. Hum. Reprod. 1995, 10:1363-1366.
25. Hommes D.W., Peppelenbosch M.P., van Deventer S.J.H. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
26. Ivanov Andrei I., Parkos Charles A., Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 2010, 177:512-524.
27. Lipschutz J.H., Li S., et al. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J. Biol. Chem. 2005, 280:3780-3788.
28. Ma Thomas Y., Iwamoto Gary K., Hoa Neil T., et al. TNF-γ-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:367-376.
29. Pastor Rojo O., Lopez San Roman A., Albeniz Arbizu E., et al. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13:269-277.
30. Ruemmele F.M., Beaulieu J.F., Dionne S., et al. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α. Gut 2002, 51:842-848.
31. Sgambati S.A., Zarif A., Basson M.D. Octreotide differentially modulates human Caco-2 intestinal epithelial cell proliferation and differentiation by decreasing intracellular cAMP. Regul. Pept. 1996, 61:219-227.
32. Smyth D., McKay Catherine M., Gulbransen Brian D., et al. Interferon-gamma signals via an ERK1/2-ARF6 pathway to promote bacterial internalization by gut epithelia. Cell. Microbiol. 2012, 14(8):1257-1270.
33. Ten B., Hofland L., van Hagen P. Somatostatin and somatostatin receptors in the immune system: a review. Eur. Cytokine Netw. 2000, 11:161-176.
34. Unno N., Wang H., Menconi M.J. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997, 113:1246-1257.
35. Van Op den Bosch J., van Nassauw L., Lantermann K., et al. Effect of intestinal inflammation on the cell-specific expression of somatostatin receptor subtypes in the murine ileum. Neurogastroenterol. Motil. 2007, 19:596-606.
36. Varma S., Breslin J.W., Lal B.K., et al. P42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc. Res. 2002, 63:172-178.
37. Vockel M., Breitenbach U., Kreienkamp H.J., Brandner J.M. Somatostatin regulates tight junction function and composition in human keratinocytes. Exp. Dermatol. 2010, 19:888-894.
38. Wang Q., Guo X.-L., Wells-Byrum D., et al. Cytokine-induced epithelia permeability changes are regulated by the activation of the P38 mitogen-activated protein kinase pathway in cultured Caco2 cells. Shock 2008, 29:531-537.
39. Wang C., Xu H., Chen H., et al. Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway. Am. J. Physiol.-Cell Physiol. 2011, 300:375-382.
40. War S.A., Kumar U. Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways: coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis. J. Mol. Signal. 2012, 7:5.
41. Wu H., Liu L., Tan Q., et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-κB cytokine pathway. J. Gastrointest. Surg. 2009, 13:983-993.
42. Xiao W.-D., Chen W., Sun L.-H., et al. The protective effect of enteric glial cells on intestinal epithelial barrier function is enhanced by inhibiting inducible nitric oxide synthase activity under lipopolysaccharide stimulation. Mol. Cell. Neurosci. 2011, 46:527-534.
43. Yasuda T., Takeyama Y., Ueda T., et al. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis. J. Surg. Res. 2006, 135:18-26.
44. Yu L.C., Flynn A.N., Turner J.R. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism. FASEB J. 2005, 19:1822-1835.
45. Yu J., Liu F., Yin P. Involvement of oxidative stress and mitogen-activated protein kinase signaling pathways in heat stress-induced injury in the rat small intestine. Stress 2013, 16:99-113.
46. Yue C., Ma B., Zhao Y., et al. Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation. Inflammation 2012, 35:1880-1888.
47. Zhou C., Li J., Wang H., Tang C. Decreased somatostatin is related to the hypersensitivity of intestinal epithelia to LPS via upregulated TLR4-TBK1 pathway in rats chronically exposed to ethanol. Alcohol 2009, 43:293-303.
48. Zhu T.J., Dong G.R., Huang G.Q., et al. The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats. Zhonghua Yi Xue Za Zhi 2007, 87:345-347.